Cost-effectiveness of Insulin Degludec Versus Insulin Glargine in Adults with Type 1 and Type 2 Diabetes Mellitus

INTRODUCTION: To estimate the cost-effectiveness of insulin degludec (IDeg) versus insulin glargine U100 (IGlar U100) and new-to-market basal insulin analogues in patients with diabetes in order to aid decision-making in a complex basal insulin market. METHODS: A simple, short-term model was used to...

Descripción completa

Detalles Bibliográficos
Autores principales: Evans, Marc, Chubb, Barrie, Gundgaard, Jens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5380498/
https://www.ncbi.nlm.nih.gov/pubmed/28210866
http://dx.doi.org/10.1007/s13300-017-0236-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5380498/
https://www.ncbi.nlm.nih.gov/pubmed/28210866
http://dx.doi.org/10.1007/s13300-017-0236-9

Ejemplares similares